RECRUITING

Strategic Targeting for Optimal Prevention of Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.

Official Title

Strategic Targeting for Optimal Prevention of Cancer

Quick Facts

Study Start:2019-03-26
Study Completion:2025-08-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03897374

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Study subjects may be included in the Clinical Trial if they meet all of the following
  1. * Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;
  2. * study subject is unable to provide an accurate history due to mental incapacity
  3. * study subject is currently abusing illicit and/or prescription drugs;

Contacts and Locations

Study Contact

C David, MBA
CONTACT
7174671201
stopcancer@callmdglobal.com

Study Locations (Sites)

Sunbeam Clinical
Prosper, Texas, 75078
United States

Collaborators and Investigators

Sponsor: ClinLogic LLC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-03-26
Study Completion Date2025-08-01

Study Record Updates

Study Start Date2019-03-26
Study Completion Date2025-08-01

Terms related to this study

Additional Relevant MeSH Terms

  • Early Detection of Cancer